National Breast Cancer Foundation
The National Breast Cancer Foundation (NBCF) is the leading community-funded organisation in Australia raising money for research into the prevention, detection and treatment of breast cancer. The NBCF recently achieved a new milestone having now funded $55 million across 230 research programs since 1994.
National Breast and Ovarian Cancer Centre
(NBOCC) is Australia's national authority and information source on breast cancer and ovarian cancer.
kConFab
kConFab brings together geneticists, clinicians, surgeon, genetic counsellors, psychosocial researchers, pathologists and epidemiologists from all over Australia and New Zealand who believe the causes and consequences of familial predisposition to breast cancer can be understood only by a concerted national effort at both the basic and clinical level.
Cheeky Checkup
Established by the NBOCC will show young women just how easy it is to be breast aware.
Breast Wishes
Breast Wishes is a new Australian musical about love, life, loss and silicon; a witty and heart-warming journey of courage and determination through laughter to triumph.
Ovarian Cancer Research Foundation
The Ovarian Cancer Research Foundation (OCRF) has been established to foster research into ovarian cancer - a disease which in Australia claims the life of one woman every 10 hours and often remains undetected until in its advanced stages.
Sarah Darmody
Sarah Darmody is an Australian author, currently living in Abu Dhabi. She is also a proud ambassador for the National Breast Cancer Foundation. Sarah is donating all the royalties from the sale of her book "Thanks for the Mammaries" to the NBCF.
Breast Cancer Network Australia
Is a national organisation for Australians personally affected by breast cancer. They offer the "my journey kit", it is a wealth of information and a very important tool in dealing with your cancer diagnosis.
Breast Screen Australia
Breast Screen aims to reduce mortality and morbidity from breast cancer by actively recruiting and screening women aged 50-69 years for early detection of the disease.
